Screener
Atea Pharmaceuticals, Inc. AVIR Q2 2026 earnings
Reported August 12, 2026 · After market close
EPS-$0.41Beat by $0.15
Revenue estimate$33.0M
EPS estimate-$0.56
Next report
Nov 11, 2026 (in 2 months)Revenue estimate$50.4M
EPS estimate-$0.51
Versus estimates
Diluted EPS
FAQ
- When did Atea Pharmaceuticals, Inc. report Q2 2026 earnings?
- Atea Pharmaceuticals, Inc. (AVIR) reported Q2 2026 earnings on August 12, 2026 after market close.
- What were Atea Pharmaceuticals, Inc.'s Q2 2026 revenue and EPS?
- Atea Pharmaceuticals, Inc. reported eps of $-0.41 for Q2 2026.
- Did Atea Pharmaceuticals, Inc. beat estimates in Q2 2026?
- EPS beat the consensus estimate of $-0.56 by $0.15.
- How did Atea Pharmaceuticals, Inc.'s Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 6.8% from $-0.44.
- Where can I find Atea Pharmaceuticals, Inc.'s Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001193125-26-346888) and the 10-Q periodic report (0001193125-26-347021) directly on SEC EDGAR. The filing index links above go to sec.gov.
